David Iwanicki - Net Worth and Insider Trading

David Iwanicki Net Worth

The estimated net worth of David Iwanicki is at least $0 dollars as of 2024-12-14. David Iwanicki is the VP, Sales & Sales Operations of PDL BioPharma Inc and owns about 0 shares of PDL BioPharma Inc (PDLI) stock worth over $0. Details can be seen in David Iwanicki's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Iwanicki has not made any transactions after 2008-01-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of David Iwanicki

David Iwanicki Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David Iwanicki owns 1 companies in total, including PDL BioPharma Inc (PDLI) .

Click here to see the complete history of David Iwanicki’s form 4 insider trades.

Insider Ownership Summary of David Iwanicki

Ticker	Comapny	Transaction Date	Type of Owner
PDLI	PDL BioPharma Inc	2008-01-02	VP & Sales & Sales Operations

David Iwanicki Latest Holdings Summary

David Iwanicki currently owns a total of 1 stock. David Iwanicki owns 0 shares of PDL BioPharma Inc (PDLI) as of January 2, 2008, with a value of $0.

Latest Holdings of David Iwanicki

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
PDLI	PDL BioPharma Inc	2008-01-02	0	2.47	0

Holding Weightings of David Iwanicki

David Iwanicki Form 4 Trading Tracker

According to the SEC Form 4 filings, David Iwanicki has made a total of 0 transactions in PDL BioPharma Inc (PDLI) over the past 5 years. The most-recent trade in PDL BioPharma Inc is the sale of 252 shares on January 2, 2008, which brought David Iwanicki around $4,344.

Insider Trading History of David Iwanicki

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

David Iwanicki Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David Iwanicki Ownership Network

Ownership Network List of David Iwanicki

No Data

Ownership Network Relation of David Iwanicki

David Iwanicki Owned Company Details

What does PDL BioPharma Inc do?

Who are the key executives at PDL BioPharma Inc?

David Iwanicki is the VP & Sales & Sales Operations of PDL BioPharma Inc. Other key executives at PDL BioPharma Inc include President and CEO Dominique Monnet , VP & Gen. Counsel & Secretary Christopher Lewis Stone , and VP Finance & CAO and Acting CFO Edward Imbrogno .

PDL BioPharma Inc (PDLI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of PDL BioPharma Inc (PDLI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PDL BioPharma Inc (PDLI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PDL BioPharma Inc (PDLI)'s detailed insider trading history can be found in Insider Trading Tracker table.

PDL BioPharma Inc Insider Transactions

No Available Data

David Iwanicki Mailing Address

Above is the net worth, insider trading, and ownership report for David Iwanicki. You might contact David Iwanicki via mailing address: 34801 Campus Drive Fremont Ca 94555.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.